Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma

Phase 2

Active, not recruiting

Conditions: Adrenocortical Carcinoma

Interventions: Drug: Pembrolizumab

First Posted Date: 2016-02-03

Last Posted Date: 2024-03-26

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 39

Registration Number: NCT02673333

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
University of Michigan (Data or Specimen Analysis Only), Ann Arbor, Michigan, United States

Pilot Trial of Homebound Stem Cell Transplantation

Not Applicable

Recruiting

Conditions: Plasma Cell Dyscrasia

Interventions: Behavioral: Home monitoring teleconsult visits
Behavioral: Patient Reported Outcomes (PRO)
Behavioral: Caregiver Reported Outcomes instruments

First Posted Date: 2016-02-02

Last Posted Date: 2024-02-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 91

Registration Number: NCT02671448

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Prospective Registry of Multiplex Testing (PROMPT)

Active, not recruiting

Conditions: Genetic Testing

Interventions: Other: saliva specimen
Behavioral: questionnaire

First Posted Date: 2016-01-27

Last Posted Date: 2024-11-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 689

Registration Number: NCT02665195

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

and more 7 locations

Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype

Not Applicable

Active, not recruiting

Conditions: Glioma
Recurrent Malignant Glioma

Interventions: Drug: Pembrolizumab

First Posted Date: 2016-01-18

Last Posted Date: 2024-12-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 27

Registration Number: NCT02658279

Locations: 🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 12 locations

BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

Not Applicable

Active, not recruiting

Conditions: Bladder Cancer
Non-Muscle-Invasive Urothelial Carcinoma

Interventions: Drug: BGJ398

First Posted Date: 2016-01-15

Last Posted Date: 2024-02-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 4

Registration Number: NCT02657486

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Single-agent Cobimetinib for Adults With Histiocytic Disorders

Phase 2

Completed

Conditions: Histiocytic Disorders

Interventions: Drug: Cobimetinib

First Posted Date: 2016-01-08

Last Posted Date: 2023-11-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 35

Registration Number: NCT02649972

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases

Phase 1

Completed

Conditions: Central Nervous System (CNS) Metastases
Metastatic Breast Cancer

Interventions: Drug: Lapatinib in Tandem With Capecitabine

First Posted Date: 2016-01-08

Last Posted Date: 2021-01-26

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 11

Registration Number: NCT02650752

Locations: 🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

and more 6 locations

Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma

Phase 1

Active, not recruiting

Conditions: Neuroblastoma
High-Risk

Interventions: Drug: cyclophosphamide
Biological: NK cells
Biological: hu3F8
Drug: rIL-2

First Posted Date: 2016-01-08

Last Posted Date: 2024-02-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 85

Registration Number: NCT02650648

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older

Phase 1

Withdrawn

Conditions: Acute Lymphoblastic Leukemia (ALL)
Newly Diagnosed Philadelphia Chromosome Negative
Aged 60 Years or Older

Interventions: Drug: Erwinia Chrysanthemi asparaginase

First Posted Date: 2016-01-06

Last Posted Date: 2017-06-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT02647190

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer

Phase 1

Completed

Conditions: Pancreatic Cancer

Interventions: Radiation: Stereotactic Body Radiotherapy (SBRT)

First Posted Date: 2015-12-31

Last Posted Date: 2024-12-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 11

Registration Number: NCT02643498

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent and follow-up only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Consent and follow-up only), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Consent and follow-up only), Montvale, New Jersey, United States

and more 4 locations

Home Terms & Conditions Privacy Policy